Loading
Loading…
Loading…
Tender ID
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹7.9 LRejected-Finance | L1 | Rejected-Finance Rate not approved in FCM | |
| 2 | L1₹43.1 LRejected-Finance 302 A WING VICTORY PARK CHANDAVARKAR ROAD BORIVALI WEST MUMBAI MAHARASHTRA 400092 | MUMBAI SUBURBAN | MAHARASHTRA | 400092 | L1 | Rejected-Finance Rate not approved in FCM | |
| 3 | L1₹51.4 LRejected-Finance 410 PLOT NO 4 DDA BUILDING LAXMI NAGAR DISTRICT CENTRE DELHI 110092 LAXMI NAGAR DELHI DELHI 110092 | EAST DELHI | DELHI | 110092 | L1 | Rejected-Finance Rate not approved in FCM | |
| 4 | L1 to L2₹75.2 LRejected-Finance 15 B 10 B A K V N INDUSTRIAL AREA RANGWASA RAO INDORE MADHYA PRADESH 453331 | INDORE | INDORE | MADHYA PRADESH | 453331 | L1 to L2 | Rejected-Finance Rate not approved in FCM | |
| 5 | L1₹87.7 LRejected-Finance | L1 | Rejected-Finance Rate not approved in FCM |
| Sl No | Description | Qty | Unit | Zydus Healthcare Limited | SAM KEM PVT LTD | VENUS REMEDIES LIMITED | CMG BIOTECH PVT. LTD. | MICRON PHARMACEUTICALS | HINDUSTAN LABORATORIES LIMITED | PRECISE BIOPHARMA PVT LTD | SERVIER INDIA PRIVATE LIMITED | SUN PHARMACEUTICAL INDUSTRIES LTD | EMCURE PHARMACEUTICALS LIMITED | Novartis Healthcare Pvt. Ltd. | Ferring Pharmaceuticals Private Limited |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.00Drugs | |||||||||||||||
| 1.01 | Petrolleum Jelly IP(500gm), Gel | 30,000 | 500 gm | - | 99.45 ₹99.45 Lowest | - | - | - | - | - | - | - | - | - | - |
| 1.02 | Povidone 500ml 10% | 32,250 | 500 ML BOTTLE | - | 129.6 ₹129.6 | - | - | - | 127.19 ₹127.19 Lowest | - | - | - | - | - | - |
| 1.03 | Prochloparazine 12.5mg Tablet | 4,350 | 10X10 | - | - | - | - | - | - | - | - | - | - | - | - |
| 1.04 | Protien + Vitamins +Corbohydrates & Minerals Powder 200gm | 9,000 | 200gm PKT | - | - | - | - | - | - | - | - | - | - | - | - |
| 1.05 | Rifaximin 550mg | 9,000 | 10TAB/STRIP | - | - | - | - | - | - | - | - | - | - | - | - |
| 1.06 | Sildenafil 20mg | 9,000 | 10X10 | - | - | - | - | - | - | - | - | - | - | - | - |
| 1.07 | Telmisartan 40mg & amlodipine 5mg + hydrochlorthaizide 12.5mg | 1,50,000 | 10Tab/Strip | - | - | - | - | - | - | - | - | - | - | - | - |
| 1.08 | Terlipressin 1mg/10ml | 2,250 | 10ML VIAL | - | - | - | - | - | - | - | - | - | - | - | - |
| 1.09 | Urokinase (5LacIU), Vial | 4,050 | 1x1 | - | - | - | - | - | - | - | - | - | - | - | - |
Tender Value
Refer Docs
EMD Value
₹2 L
Closing Date
6 Nov 2025, 3:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Managing Director
MPPHSCL, Bhopal
Online Tender for the Rate Contract and Supply of Pharmaceuticals to Various Hospitals of Government of Madhya Pradesh for a Period of 18 months
2025_PHSCL_454555_1
T-732/MPPHSCL/Pharma/RC/2025 Date-26-09-2025
Open Tender
Medicines
Item Wise
45 days
MPPHSCL
Please refer Tender documents.
23 documents required · 23 mandatory
₹6,490
Yes
₹2 L
Yes
MPPHSCL, Bhopal
19 May 2026
26 Sept 2025
7 Nov 2025
26 Sept 2025
6 Nov 2025
15 Oct 2025
29 Sept 2025
stage.html
html • 0.08 MB
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
cancelled_1.pdf
pdf • 0.27 MB
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.04 MB
Tendernotice_1.pdf
PDF • 0.88 MB
TenderDocumentT732.pdf
Tender Documents • 2.17 MB
SupplierFirmBiddingFormChecklistIIAnnexureXVIIIT732.rar
Other Document • 0.05 MB
ItemListT732.pdf
Other Document • 0.51 MB
BOQ_534830.xls
BOQ • 0.41 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .